Product Information

VEMLIDY 25 MG TABLET is a brand product labeled by Gilead Sciences, Inc., priced at $52.0039 per EA under NDC 61958230101. Its NADAC has been published 496 times since May 17, 2017.

FDA first approved this application on Nov 10, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

VEMLIDY 25 MG TABLET

tenofovir alafenamide
$52.0039per EA

Strength

25 mg/1

NDC

61958230101

Classification

Brand

Dosage Form

TABLET

Route

ORAL

Effective Date

10/21/2026

Approval Type

New Drug (NDA)

FDA Application

NDA208464

FDA Approved

11/10/2016

TE Code

AB

On Market Since

11/10/2016

Price Statistics

The NADAC for VEMLIDY 25 MG TABLET has been published 496 times since May 17, 2017, and over the history we have for it it has risen 63.1%. The table below summarizes its recorded NADAC range and movement.

Current price$52.0039 per EA
All-time high$52.0039 (Nov 11, 2026)
All-time low$31.8880 (May 17, 2017)
52-week high$52.0039
52-week low$49.0282
Median price$41.7796
Average price$41.4222
Largest weekly change+6.9% (Jan 10, 2018)
Weeks tracked496
Tracking sinceMay 17, 2017

Price History

1W

0.0%

1M

+0.0%

3M

+0.1%

6M

+0.1%

1Y

+6.1%

3Y

+17.5%

5Y

+31.9%

All

+63.1%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the tenofovir alafenamide market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of VEMLIDY 25 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for VEMLIDY 25 MG TABLET, manufactured by Gilead Sciences, Inc., is $52.0039 per EA (NDC 61958230101), effective Nov 11, 2026.

How has the price of VEMLIDY 25 MG TABLET changed over time?

Over the history we have for it, the NADAC for VEMLIDY 25 MG TABLET has risen 63.1%. It has been tracked across 496 weekly CMS publications since May 17, 2017.

What are the highest and lowest recorded NADAC prices for VEMLIDY 25 MG TABLET?

Since May 17, 2017, the NADAC for VEMLIDY 25 MG TABLET has ranged from a low of $31.8880 (May 17, 2017) to a high of $52.0039 (Nov 11, 2026), with a median of $41.7796 per EA.

Are there cheaper alternatives to VEMLIDY 25 MG TABLET?

No other NADAC-published product currently shares the active ingredient and strength of VEMLIDY 25 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures VEMLIDY 25 MG TABLET?

VEMLIDY 25 MG TABLET (NDC 61958230101) is labeled by Gilead Sciences, Inc., and CMS classifies it as a brand product.